Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 27, 2018 13:26 ET | Source: GeneTx Biotherapeutics LLC.

GeneTx Biotherapeutics receives FDA orphan-drug designation for Angelman syndrome treatment

DOWNERS GROVE, Ill., March 27, 2018 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration has granted orphan-drug designation to GeneTx Biotherapeutics LLC’s GTX-101 for the treatment of...